Patent expiry dates for biologicals: 2018 update

Author(s): GaBI Journal Editor, GaBI Online Editor

Abstract: Over the last few years, there has been a shift in the landscape of blockbuster medicines from small molecule drugs to biologicals. While small molecule drugs still dominate the global pharmaceutical market in terms of numbers, seven of the top 10 best-selling medicines in 2018 were biologicals. The high and rising cost of biologicals […]

Read more →